GlassScriptPhysician profile
Anne C Csere
NPI 1841420775
$29,332.36
in general payments reported to CMS, 2019-2025
11 companies · $8,411 in 2025
The $8,411 reported for 2025 was more than what 89% of Neurology With Special Qualifications In Child Neurology providers received nationally (typical 2025 total: $275).
See the full distribution for Neurology with Special Qualifications in Child Neurology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $396 · 2021: $234 · 2022: $135 · 2023: $13K · 2024: $6,725 · 2025: $8,411.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $19K · Honoraria: $7,764 · Food and Beverage: $1,905.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $18,900.00 |
| Honoraria | $7,763.50 |
| Food and Beverage | $1,904.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $19,661.87 | 2021-2024 | Qulipta, Ubrelvy, Botox |
| Axsome Therapeutics, INC. | $8,046.30 | 2025 | Symbravo |
| Teva Pharmaceuticals USA, INC. | $667.29 | 2019-2025 | Ajovy, Austedo Xr |
| Amgen INC. | $610.60 | 2019-2023 | Aimovig |
| Lundbeck LLC | $123.69 | 2025 | Vyepti |
| Lilly USA, LLC | $90.83 | 2019 | |
| Novartis Pharmaceuticals Corporation | $50.00 | 2019 | |
| Sk Life Science, INC. | $32.56 | 2025 | |
| Pfizer INC. | $18.95 | 2023 | |
| Allergan, INC. | $16.62 | 2019 | |
| Ucb, INC. | $13.65 | 2025 | Nayzilam |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anne Csere listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.